Torrent Pharmaceuticals has reignited negotiations to acquire private equity firm KKR’s 47.8% controlling stake in J.B. Chemicals & Pharmaceuticals. This move comes nearly 10 months after initial talks stalled. The proposed deal is valued at approximately $2.4 billion, and Torrent is

Continue ReadingKKR stake sale JB Chemicals.